Clinical Trials Directory

Trials / Terminated

TerminatedNCT03748511

Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

This study investigates the relation between the gastrointestinal tract bacteria and the progression of fatty liver disease .

Detailed description

In the gastrointestinal (GI) tract live wide spectrum of bacteria, in this study we are trying to find if there is a relation between the GI tract bacteria and the development of non alcoholic fatty liver disease, the results of the this study may help us identify the stage of liver disease in noninvasive means and enables us to adopt methods to reduce morbodity.

Conditions

Interventions

TypeNameDescription
OTHERfibroscan and stool samplepatients undergo ultrasaound (fibroscan) in order to stage the liver disease.

Timeline

Start date
2019-03-05
Primary completion
2022-09-08
Completion
2022-09-08
First posted
2018-11-21
Last updated
2023-03-06

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03748511. Inclusion in this directory is not an endorsement.